This company has been acquired
Resumen de acción CSII
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Competidores de Cardiovascular Systems, Inc.
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | US$20.00 |
52 Week High | US$20.57 |
52 Week Low | US$12.26 |
Beta | 0.74 |
1 Month Change | 0.70% |
3 Month Change | 49.48% |
1 Year Change | 1.63% |
3 Year Change | -52.38% |
5 Year Change | -25.90% |
Change since IPO | 123.46% |
Noticias y actualizaciones recientes
Recent updates
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate
Feb 03We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely
Oct 12Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Aug 03Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?
Oct 09At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?
Sep 18Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?
Jun 24Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Jun 03We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow
Apr 29Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain
Feb 10Cardiovascular Systems misses on revenue
Feb 03Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares
Dec 11Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Nov 06Rentabilidad de los accionistas
CSII | US Medical Equipment | Mercado US | |
---|---|---|---|
7D | 0.1% | -4.4% | -3.7% |
1Y | 1.6% | -2.8% | 20.2% |
Rentabilidad vs. Industria: CSII exceeded the US Medical Equipment industry which returned -0.1% over the past year.
Rentabilidad vs. Mercado: CSII exceeded the US Market which returned -5.3% over the past year.
Volatilidad de los precios
CSII volatility | |
---|---|
CSII Average Weekly Movement | 14.0% |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CSII's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: CSII's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1989 | 725 | Scott Ward | www.csi360.com |
Resumen de fundamentos de Cardiovascular Systems, Inc.
Estadísticas fundamentales de CSII | |
---|---|
Capitalización bursátil | US$843.96m |
Beneficios(TTM) | -US$37.87m |
Ingresos (TTM) | US$239.84m |
3.5x
Ratio precio-ventas (PS)-22.3x
Ratio precio-beneficio (PE)¿Está CSII sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de CSII | |
---|---|
Ingresos | US$239.84m |
Coste de los ingresos | US$66.22m |
Beneficio bruto | US$173.63m |
Otros gastos | US$211.49m |
Beneficios | -US$37.87m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | -0.90 |
Margen bruto | 72.39% |
Margen de beneficio neto | -15.79% |
Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado CSII a largo plazo?
Ver rendimiento histórico y comparativa